(Q38320545)

2 September 2017

0 references

1 reference

title

Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials (English)

1 reference

2 September 2017

1 reference

C Wang

1

1 reference

2 September 2017

J Mamza

series ordinal

2

1 reference

2 September 2017

I Idris

series ordinal

3

1 reference

2 September 2017

publication date

13 February 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

32

1 reference

2 September 2017

issue

5

1 reference

2 September 2017

page(s)

585-594

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

2 September 2017

cites work

1 reference

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

Methods to enhance delivery of prandial insulin and basal-prandial insulin

21 January 2018

1 reference

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

Insulin treatment for type 2 diabetes: when to start, which to use.

21 January 2018

1 reference

Correlates of insulin injection omission

21 January 2018

1 reference

The use of fixed-mixture insulins in clinical practice

21 January 2018

1 reference

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design

21 January 2018

1 reference

Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemi

21 January 2018

1 reference

DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes

21 January 2018

1 reference

Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial

21 January 2018

1 reference

A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.

21 January 2018

1 reference

Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study

21 January 2018

1 reference

Prandial–basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetes

21 January 2018

1 reference

Glycemic control with insulin glargine plus insulin glulisine versus premixed insulin analogues in real-world practices: a cost-effectiveness study with a randomized pragmatic trial design

21 January 2018

1 reference

Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.

21 January 2018

1 reference

Comparison of thrice daily biphasic human insulin (30/70) versus basal detemir & bolus aspart in patients with poorly controlled type 2 diabetes mellitus - a pilot study

21 January 2018

1 reference

Six-month multicentric, open-label, randomized trial of twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart in Japanese type 2 diabetic patients (JDDM 11).

21 January 2018

1 reference

Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy

21 January 2018

1 reference

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

Adaptation of the Diabetes Health Profile (DHP-1) for use with patients with Type 2 diabetes mellitus: psychometric evaluation and cross-cultural comparison

21 January 2018

1 reference

Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses

21 January 2018

1 reference

Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes

21 January 2018

1 reference

Three-year efficacy of complex insulin regimens in type 2 diabetes

21 January 2018

1 reference

Hypoglycemia in diabetes.

21 January 2018

1 reference

Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DME.12694

1 reference

2 September 2017

1 reference